ScholarLens Back to search
2013•Value in HealthOpen access

Treatment Patterns of Ranibizumab and Aflibercept for the Management of Wet Age-Related Macular Degeneration in Routine Clinical Practice in the United States

A. Ferreira, Alexandros Sagkriotis, Fran Milnes, Melvin Skip Olson, J. W. Hill, J. Lu, Charles Makin

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Aflibercept, Ranibizumab, Medicine, Macular degeneration, Ophthalmology, Medical prescription, Loading dose, Surgery

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Treatment Patterns of Ranibizumab and Aflibercept for the Management of Wet Age-Related Macular Degeneration in Routine Clinical Practice in the United States — Research Paper | ScholarLens